News

Advanced Medical Solutions Group plc – Notice of Interim Results

Winsford, UK: Advanced Medical Solutions Group plc (AIM:AMS),…

Leucid Bio to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

London, UK – 28 August 2025 – Leucid Bio ("Leucid" or the…

Kling Bio Announces Collaboration with Sanofi for Accelerated Discovery of Neutralizing Antibodies

Leverages Kling’s technology to discover hard-to-find,…

Neuraxpharm continues international expansion with launch of Neuraxpharm Australia

Avendran Naidu appointed Head of Commercial to lead new affiliate CNS…

Sanofi to acquire next-generation vaccine biotech Vicebio for US$1.6 billion

Sanofi will gain access to Molecular Clamp technology that…

EIFO and the Novo Nordisk Foundation Acquire the World’s Most Powerful Quantum Computer  

EIFO, the export and investment fund of Denmark, and the Novo…
xeltis

Xeltis announces positive data for Xabg, its coronary artery bypass conduit, in EU clinical trial

Preliminary clinical data from Xabg, Xeltis’ coronary artery…

One Biosciences Announces €15 Million Series A Financing to Advance Clinical Single Cell Profiling

Funding will be used to establish the clinical utility of…

Heidelberg Pharma Reports on First Half-Year 2025 and the Positive Course of Business

Clinical trial with ATAC candidate HDP-101 in multiple myeloma…

Actithera Raises $75.5M in Oversubscribed Series A Financing to Redefine Precision Radioligand Therapy

Series A co-led by founding investor M Ventures and new lead…

Jacob Falck Hansen appointed as Chief Executive Officer of Vesper Bio

Copenhagen, Denmark, 01 July 2025 – Vesper Bio ApS (“Vesper”…

We’d love to hear from you

For more information about Optimum Strategic Communications, please get in touch.

© Optimum Strategic Communications.